Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC CPD-1224 | 2891620-68-9 | C43H47ClN8O7S | 100 MG
SDP

Supplier:  Medchemexpress LLC HY153386100MG

Encompass_Preferred

CPD-1224 is an orally effective ALK inhibitor derived from an ALK inhibitor that connects to the cereblon ligand. It targets the EML4-ALK oncogenic fusion protein, leading to the degradation of both ALK and its mutant forms L1196M/G1202R. This compound has the potential to slow down tumor growth and is for research use only.

  • Enhances kinase binding selectivity and exhibits good degradation selectivity
  • Shows antiproliferative activity against mouse Ba/F3 cells
  • Demonstrates oral bioavailability of 28% in mice (10 mg/kg, oral)
  • Inhibits tumor growth in mice by reducing total ALK and phosphorylated ALK levels

Catalog No. 50-003-73243


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.